What are the key elements of digital patient engagement?
At MedCity ENGAGE on November 7, leaders from Dignity Health and UC San Diego Health discussed challenges to IT adoption as well as how technology can benefit patients and clinicians.
How to improve geriatric care in the ER, which today lies between wilderness and cruise ship medicine
A fireside chat at MedCity's ENGAGE conference explored how to improve geriatric care in the ER from using ambient lighting and reducing noise levels to providing support for stressed family caregivers.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
UCSD, Isis Pharmaceuticals enter CRISPR gene editing race
Isis Pharmaceuticals has teamed up with UCSD to demonstrate a commercially feasible way to use RNA to control CRISPR gene editing.
Meghana Keshavan will speak at UCSD Ethics Center
MedCity News' Meghana Keshavan will speak on a panel about the ethics of life sciences journalism at a program arranged by the University of California, San Diego Ethics Center.
That RNAi startup whose founder was shot by a disgrunted biotech exec just raised $7.5M
Solstice Biologics, an interesting RNAi therapeutics company that has attracted attention for the wrong reasons, has raised $7.5 million, according to a regulatory filing, building on the $18 million raised last year from venBio and Aeris Capital. The San Francisco company is figuring out how to get RNAi-based drugs to cross multiple cell types to treat different […]
Understanding Down syndrome could be key in understanding Alzheimer’s, researchers say
Researchers at the University of California, San Diego worked with a surprising cohort when testing an experimental Alzheimer’s drug – they sought out people with Down syndrome. National Public Radio put together a nice piece on the study, and why those with Down syndrome are an ideal subset to understand Alzheimer’s: “By the age of 40, […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.